These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 9850425
1. Pharmacokinetics of deramciclane in rabbits. Lengyel J, Bojti E, Bolehovszky A, Grézal G, Klebovich I, Magyar K. Arzneimittelforschung; 1998 Nov; 48(11):1063-8. PubMed ID: 9850425 [Abstract] [Full Text] [Related]
2. Oral, intraperitoneal and intravenous pharmacokinetics of deramciclane and its N-desmethyl metabolite in the rat. Nemes KB, Abermann M, Bojti E, Grézal G, Al-Behaisi S, Klebovich I. J Pharm Pharmacol; 2000 Jan; 52(1):47-51. PubMed ID: 10716602 [Abstract] [Full Text] [Related]
3. Absorption of the new anxiolytic compound deramciclane in rats, dogs and rabbits. Lengyel J, Bolehovszky A, Klebovich I, Aberman M, Magyar K. Arzneimittelforschung; 1998 May; 48(5):455-60. PubMed ID: 9638311 [Abstract] [Full Text] [Related]
4. Pharmacokinetics of deramciclane in dogs after single oral and intravenous dosing and multiple oral dosing. Kanerva H, Huuskonen H, Alhonen-Raatesalmi A, Nevalainen T, Urtti A. Biopharm Drug Dispos; 1998 Nov; 19(8):531-9. PubMed ID: 9840215 [Abstract] [Full Text] [Related]
5. Pharmacokinetics of deramciclane, a novel anxiolytic agent, after intravenous and oral administration. Huupponen R, Paija O, Salonen M, Björklund H, Rouru J, Anttila M. Drugs R D; 2003 Nov; 4(6):339-45. PubMed ID: 14584962 [Abstract] [Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery. Dow J, Dulery BD, Hornsperger JM, Di Francesco GF, Keshary P, Haegele KD. Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078 [Abstract] [Full Text] [Related]
10. Pharmacokinetics of deramciclane and N-desmethylderamciclane after single and repeated oral doses in healthy volunteers. Huupponen R, Anttila M, Rouru J, Kanerva H, Miettinen T, Scheinin M. Int J Clin Pharmacol Ther; 2004 Aug; 42(8):449-55. PubMed ID: 15366325 [Abstract] [Full Text] [Related]
11. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs. Park BK, Lim JH, Kim MS, Hwang YH, Yun HI. Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454 [Abstract] [Full Text] [Related]
13. Enantioselective pharmacokinetics of racemic carprofen in New Zealand white rabbits. Hawkins MG, Taylor IT, Craigmill AL, Tell LA. J Vet Pharmacol Ther; 2008 Oct; 31(5):423-30. PubMed ID: 19000261 [Abstract] [Full Text] [Related]
14. Distribution of deramciclane (EGIS-3886) in rat brain regions. Magyar K, Lengyel J, Klebovich I, Urmös I, Grézal G. Eur J Drug Metab Pharmacokinet; 1998 Oct; 23(2):125-31. PubMed ID: 9725469 [Abstract] [Full Text] [Related]
17. Influence of food on the oral bioavailability of deramciclane from film-coated tablet in healthy male volunteers. Drabant S, Nemes KB, Horváth V, Tolokán A, Grézal G, Anttila M, Gachályi B, Kanerva H, Al-Behaisi S, Horvai G, Klebovich I. Eur J Pharm Biopharm; 2004 Nov; 58(3):689-95. PubMed ID: 15451546 [Abstract] [Full Text] [Related]
18. Analytical determination and pharmacokinetics of robenacoxib in the dog. Jung M, Lees P, Seewald W, King JN. J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454 [Abstract] [Full Text] [Related]
19. Pharmacokinetics of PFA (trisodium phosphonoformate) after i.v. and p.o. administration to beagle dogs and rabbits. Ritschel WA, Grummich KW, Hussain SA. Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):41-8. PubMed ID: 3157841 [Abstract] [Full Text] [Related]